SMPD2 and osteoporosis: We preincubated Chr colonies with GW4869, a neutral sphingomyelinase (nSMase) inhibitor that limits EV release and stops Chr colonies from secreting EVs, in order to investigate the function of EVs in Chr-induced anti-osteoporosis.